Publications in collaboration with researchers from Centro de Investigación Cooperativa en Biotecnología (31)

2024

  1. Human Leukocyte Antigen Signatures as Pathophysiological Discriminants of Microscopic Colitis Subtypes

    Journal of Crohn's and Colitis, Vol. 18, Núm. 3, pp. 349-359

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Combining Asian and European genome-wide association studies of colorectal cancer improves risk prediction across racial and ethnic populations

    Nature Communications, Vol. 14, Núm. 1

  3. Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma

    Journal of Hepatology, Vol. 79, Núm. 1, pp. 93-108

  4. Sucrase-isomaltase genotype and response to a starch-reduced and sucrose-reduced diet in IBS-D patients

    Gut

2022

  1. A survey of functional dyspepsia in 361,360 individuals: Phenotypic and genetic cross-disease analyses

    Neurogastroenterology and Motility, Vol. 34, Núm. 6

  2. Detailed stratified GWAS analysis for severe COVID-19 in four European populations

    Human Molecular Genetics, Vol. 31, Núm. 23, pp. 3945-3966

  3. Local genetic variation of inflammatory bowel disease in Basque population and its effect in risk prediction

    Scientific Reports, Vol. 12, Núm. 1

  4. Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental models

    Journal of Hepatology, Vol. 77, Núm. 1, pp. 177-190

2021

  1. Anti-miR-518d-5p overcomes liver tumor cell death resistance through mitochondrial activity

    Cell Death and Disease, Vol. 12, Núm. 6

  2. Could protein content of urinary extracellular vesicles be useful to detect cirrhosis in alcoholic liver disease?

    International Journal of Biological Sciences, Vol. 17, Núm. 8, pp. 1864-1877

  3. E2F1 and E2F2-mediated repression of CPT2 establishes a lipid-rich tumor-promoting environment

    Cancer Research, Vol. 81, Núm. 11, pp. 2874-2887

  4. GWAS of stool frequency provides insights into gastrointestinal motility and irritable bowel syndrome

    Cell Genomics, Vol. 1, Núm. 3

  5. Inhibition of NAE-dependent protein hyper-NEDDylation in cystic cholangiocytes halts cystogenesis in experimental models of polycystic liver disease

    United European Gastroenterology Journal, Vol. 9, Núm. 7, pp. 848-859

  6. Interplay between genome, metabolome and microbiome in colorectal cancer

    Cancers, Vol. 13, Núm. 24

  7. TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms

    Gut, Vol. 70, Núm. 7, pp. 1345-1361

  8. Targeting UBC9-mediated protein hyper-SUMOylation in cystic cholangiocytes halts polycystic liver disease in experimental models

    Journal of Hepatology, Vol. 74, Núm. 2, pp. 394-406

2020

  1. A novel serum metabolomic profile for the differential diagnosis of distal cholangiocarcinoma and pancreatic ductal adenocarcinoma

    Cancers, Vol. 12, Núm. 6

  2. Integrative analysis of fecal metagenomics and metabolomics in colorectal cancer

    Cancers, Vol. 12, Núm. 5

  3. Liver osteopontin is required to prevent the progression of age-related nonalcoholic fatty liver disease

    Aging Cell, Vol. 19, Núm. 8